Literature DB >> 23124076

Differentiation within autologous fibrin scaffolds of porcine dermal cells with the mesenchymal stem cell phenotype.

Pilar de la Puente1, Dolores Ludeña, Marta López, Jennifer Ramos, Javier Iglesias.   

Abstract

Porcine mesenchymal stem cells (pMSCs) are an attractive source of cells for tissue engineering because their properties are similar to those of human stem cells. pMSCs can be found in different tissues but their dermal origin has not been studied in depth. Additionally, MSCs differentiation in monolayer cultures requires subcultured cells, and these cells are at risk of dedifferentiation when implanting them into living tissue. Following this, we attempted to characterize the MSCs phenotype of porcine dermal cells and to evaluate their cellular proliferation and differentiation in autologous fibrin scaffolds (AFSs). Dermal biopsies and blood samples were obtained from 12 pigs. Dermal cells were characterized by flow cytometry. Frozen autologous plasma was used to prepare AFSs. pMSC differentiation was studied in standard structures (monolayers and pellets) and in AFSs. The pMSCs expressed the CD90 and CD29 markers of the mesenchymal lineage. AFSs afforded adipogenic, osteogenic and chondrogenic differentiation. The porcine dermis can be proposed to be a good source of MSCs with adequate proliferative capacity and a suitable expression of markers. The pMSCs also showed optimal proliferation and differentiation in AFSs, such that these might serve as a promising autologous and implantable material for use in tissue engineering.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23124076     DOI: 10.1016/j.yexcr.2012.10.009

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  9 in total

1.  Newly established myeloma-derived stromal cell line MSP-1 supports multiple myeloma proliferation, migration, and adhesion and induces drug resistance more than normal-derived stroma.

Authors:  Pilar de la Puente; Nancy Quan; Ryan Soo Hoo; Barbara Muz; Rebecca C Gilson; Micah Luderer; Justin King; Samuel Achilefu; Noha Nabil Salama; Ravi Vij; Abdel Kareem Azab
Journal:  Haematologica       Date:  2016-04-14       Impact factor: 9.941

2.  3D tissue-engineered bone marrow as a novel model to study pathophysiology and drug resistance in multiple myeloma.

Authors:  Pilar de la Puente; Barbara Muz; Rebecca C Gilson; Feda Azab; Micah Luderer; Justin King; Samuel Achilefu; Ravi Vij; Abdel Kareem Azab
Journal:  Biomaterials       Date:  2015-09-12       Impact factor: 12.479

3.  Enhancing proteasome-inhibitory activity and specificity of bortezomib by CD38 targeted nanoparticles in multiple myeloma.

Authors:  Pilar de la Puente; Micah J Luderer; Cinzia Federico; Abbey Jin; Rebecca C Gilson; Christopher Egbulefu; Kinan Alhallak; Shruti Shah; Barbara Muz; Jennifer Sun; Justin King; Daniel Kohnen; Noha Nabil Salama; Samuel Achilefu; Ravi Vij; Abdel Kareem Azab
Journal:  J Control Release       Date:  2017-11-28       Impact factor: 9.776

Review 4.  An overview on autologous fibrin glue in bone tissue engineering of maxillofacial surgery.

Authors:  Azizollah Khodakaram-Tafti; Davood Mehrabani; Hanieh Shaterzadeh-Yazdi
Journal:  Dent Res J (Isfahan)       Date:  2017 Mar-Apr

5.  Human Plasma-Derived 3D Cultures Model Breast Cancer Treatment Responses and Predict Clinically Effective Drug Treatment Concentrations.

Authors:  Kristin Calar; Simona Plesselova; Somshuvra Bhattacharya; Megan Jorgensen; Pilar de la Puente
Journal:  Cancers (Basel)       Date:  2020-06-29       Impact factor: 6.639

6.  Culture and characterization of various porcine integumentary-connective tissue-derived mesenchymal stromal cells to facilitate tissue adhesion to percutaneous metal implants.

Authors:  Devaveena Dey; Nicholas G Fischer; Andrea H Dragon; Elsa Ronzier; Isha Mutreja; David T Danielson; Cole J Homer; Jonathan A Forsberg; Joan E Bechtold; Conrado Aparicio; Thomas A Davis
Journal:  Stem Cell Res Ther       Date:  2021-12-18       Impact factor: 6.832

7.  Autologous or heterologous fibrin sealant scaffold: which is the better choice?

Authors:  Rui Seabra Ferreira
Journal:  J Venom Anim Toxins Incl Trop Dis       Date:  2014-07-18

Review 8.  Current development of biodegradable polymeric materials for biomedical applications.

Authors:  Richard Song; Maxwell Murphy; Chenshuang Li; Kang Ting; Chia Soo; Zhong Zheng
Journal:  Drug Des Devel Ther       Date:  2018-09-24       Impact factor: 4.162

9.  Analysis of Dual Class I Histone Deacetylase and Lysine Demethylase Inhibitor Domatinostat (4SC-202) on Growth and Cellular and Genomic Landscape of Atypical Teratoid/Rhabdoid.

Authors:  Mariah M Hoffman; Jessica S Zylla; Somshuvra Bhattacharya; Kristin Calar; Timothy W Hartman; Ratan D Bhardwaj; W Keith Miskimins; Pilar de la Puente; Etienne Z Gnimpieba; Shanta M Messerli
Journal:  Cancers (Basel)       Date:  2020-03-23       Impact factor: 6.639

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.